Clinical Trials Browser

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Neuroendocrine

Esophageal Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Neuroendocrine Tumors

Cancer Patients Referred to do PET/CT Study

Pancreatic Ductal Adenocarcinoma

Thyroid Neoplasms

Lung Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Aggression, Lymphoma, B-Cell

Myocarditis, Hematologic Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Brain Neoplasms

Lymphoma, Follicular

Intraabdominal Infections

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Neoplasms, Plasma Cell

Carcinoma, Neuroendocrine

Liver Malignancy

Mouth Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

Large B-cell Lymphoma

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

Smoking Cessation, Multiple Pulmonary Nodules

Brain Neoplasms

Glioma, Parkinson Disease, Prostatic Neoplasms

Clinical Trials

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

18F-FDG PET/CT

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

CONPET

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.

68Ga-FAPI PET/CT in Malignant Tumors

FAPI-OSCC

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer

Integrin αvβ6-targeted PET in Malignant Tumors

89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)

Biomarkers to Detect Endocrine Therapy Resistance

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique